Beta-endorphin cell therapy for cancer prevention

Changqing Zhang, Sengottuvelan Murugan, Nadka Boyadjieva, Shaima Jabbar, Pallavi Shrivastava, Dipak K. Sarkar

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

β-Endorphin (BEP)-producing neuron in the hypothalamus plays a key role in bringing the stress axis to a state of homeostasis and maintaining body immune defense system. Long-term delivery of BEP to obtain beneficial effect on chemoprevention is challenging, as the peptides rapidly develop tolerance. Using rats as animal models, we show here that transplantation of BEP neurons into the hypothalamus suppressed carcinogens- and hormone-induced cancers in various tissues and prevented growth and metastasis of established tumors via activation of innate immune functions. In addition, we show that intracerebroventricular administration of nanosphere-attached dibutyryl cyclic adenosine monophosphate (dbcAMP) increased the number of BEP neurons in the hypothalamus, reduced the stress response, enhanced the innate immune function, and prevented tumor cell growth, progression, and metastasis. BEP neuronal supplementation did not produce any deleterious effects on general health but was beneficial in suppressing age-induced alterations in physical activity, metabolic, and immune functions. We conclude that the neuroimmune system has significant control over cancer growth and progression, and that activation of the neuroimmune system via BEP neuronal supplementation/induction may have therapeutic value for cancer prevention and improvement of general health.

Original languageEnglish (US)
Pages (from-to)56-67
Number of pages12
JournalCancer Prevention Research
Volume8
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

beta-Endorphin
Cell- and Tissue-Based Therapy
Hypothalamus
Neoplasms
Neurons
Growth
Nanospheres
Neoplasm Metastasis
Endorphins
Chemoprevention
Health
Innate Immunity
Carcinogens
Cyclic AMP
Immune System
Homeostasis
Animal Models
Transplantation
Hormones
Peptides

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Zhang, C., Murugan, S., Boyadjieva, N., Jabbar, S., Shrivastava, P., & Sarkar, D. K. (2015). Beta-endorphin cell therapy for cancer prevention. Cancer Prevention Research, 8(1), 56-67. https://doi.org/10.1158/1940-6207.CAPR-14-0254
Zhang, Changqing ; Murugan, Sengottuvelan ; Boyadjieva, Nadka ; Jabbar, Shaima ; Shrivastava, Pallavi ; Sarkar, Dipak K. / Beta-endorphin cell therapy for cancer prevention. In: Cancer Prevention Research. 2015 ; Vol. 8, No. 1. pp. 56-67.
@article{c46876f7fc424f3e9bd660d625fbfd14,
title = "Beta-endorphin cell therapy for cancer prevention",
abstract = "β-Endorphin (BEP)-producing neuron in the hypothalamus plays a key role in bringing the stress axis to a state of homeostasis and maintaining body immune defense system. Long-term delivery of BEP to obtain beneficial effect on chemoprevention is challenging, as the peptides rapidly develop tolerance. Using rats as animal models, we show here that transplantation of BEP neurons into the hypothalamus suppressed carcinogens- and hormone-induced cancers in various tissues and prevented growth and metastasis of established tumors via activation of innate immune functions. In addition, we show that intracerebroventricular administration of nanosphere-attached dibutyryl cyclic adenosine monophosphate (dbcAMP) increased the number of BEP neurons in the hypothalamus, reduced the stress response, enhanced the innate immune function, and prevented tumor cell growth, progression, and metastasis. BEP neuronal supplementation did not produce any deleterious effects on general health but was beneficial in suppressing age-induced alterations in physical activity, metabolic, and immune functions. We conclude that the neuroimmune system has significant control over cancer growth and progression, and that activation of the neuroimmune system via BEP neuronal supplementation/induction may have therapeutic value for cancer prevention and improvement of general health.",
author = "Changqing Zhang and Sengottuvelan Murugan and Nadka Boyadjieva and Shaima Jabbar and Pallavi Shrivastava and Sarkar, {Dipak K.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1158/1940-6207.CAPR-14-0254",
language = "English (US)",
volume = "8",
pages = "56--67",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

Zhang, C, Murugan, S, Boyadjieva, N, Jabbar, S, Shrivastava, P & Sarkar, DK 2015, 'Beta-endorphin cell therapy for cancer prevention', Cancer Prevention Research, vol. 8, no. 1, pp. 56-67. https://doi.org/10.1158/1940-6207.CAPR-14-0254

Beta-endorphin cell therapy for cancer prevention. / Zhang, Changqing; Murugan, Sengottuvelan; Boyadjieva, Nadka; Jabbar, Shaima; Shrivastava, Pallavi; Sarkar, Dipak K.

In: Cancer Prevention Research, Vol. 8, No. 1, 01.01.2015, p. 56-67.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Beta-endorphin cell therapy for cancer prevention

AU - Zhang, Changqing

AU - Murugan, Sengottuvelan

AU - Boyadjieva, Nadka

AU - Jabbar, Shaima

AU - Shrivastava, Pallavi

AU - Sarkar, Dipak K.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - β-Endorphin (BEP)-producing neuron in the hypothalamus plays a key role in bringing the stress axis to a state of homeostasis and maintaining body immune defense system. Long-term delivery of BEP to obtain beneficial effect on chemoprevention is challenging, as the peptides rapidly develop tolerance. Using rats as animal models, we show here that transplantation of BEP neurons into the hypothalamus suppressed carcinogens- and hormone-induced cancers in various tissues and prevented growth and metastasis of established tumors via activation of innate immune functions. In addition, we show that intracerebroventricular administration of nanosphere-attached dibutyryl cyclic adenosine monophosphate (dbcAMP) increased the number of BEP neurons in the hypothalamus, reduced the stress response, enhanced the innate immune function, and prevented tumor cell growth, progression, and metastasis. BEP neuronal supplementation did not produce any deleterious effects on general health but was beneficial in suppressing age-induced alterations in physical activity, metabolic, and immune functions. We conclude that the neuroimmune system has significant control over cancer growth and progression, and that activation of the neuroimmune system via BEP neuronal supplementation/induction may have therapeutic value for cancer prevention and improvement of general health.

AB - β-Endorphin (BEP)-producing neuron in the hypothalamus plays a key role in bringing the stress axis to a state of homeostasis and maintaining body immune defense system. Long-term delivery of BEP to obtain beneficial effect on chemoprevention is challenging, as the peptides rapidly develop tolerance. Using rats as animal models, we show here that transplantation of BEP neurons into the hypothalamus suppressed carcinogens- and hormone-induced cancers in various tissues and prevented growth and metastasis of established tumors via activation of innate immune functions. In addition, we show that intracerebroventricular administration of nanosphere-attached dibutyryl cyclic adenosine monophosphate (dbcAMP) increased the number of BEP neurons in the hypothalamus, reduced the stress response, enhanced the innate immune function, and prevented tumor cell growth, progression, and metastasis. BEP neuronal supplementation did not produce any deleterious effects on general health but was beneficial in suppressing age-induced alterations in physical activity, metabolic, and immune functions. We conclude that the neuroimmune system has significant control over cancer growth and progression, and that activation of the neuroimmune system via BEP neuronal supplementation/induction may have therapeutic value for cancer prevention and improvement of general health.

UR - http://www.scopus.com/inward/record.url?scp=84920825017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920825017&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-14-0254

DO - 10.1158/1940-6207.CAPR-14-0254

M3 - Article

C2 - 25403848

AN - SCOPUS:84920825017

VL - 8

SP - 56

EP - 67

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 1

ER -